BMS-938790

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBMS-938790
Drug Alias NameBMS-938790
ClassificationBiologics
Mechanisms of ActionInterleukin-23 stimulantsSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3Interleukin-23
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdnexus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdnexus TherapeuticsBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A